ASM COVID-19 Initiatives
As the COVID-19 pandemic evolves, ASM is responding, from free access to coronavirus-related research from our journals, to advocating for the funding and resources we need to combat SARS-CoV-2. See what we're doing:
- Shaping the U.S. response.
- Leading on diagnostics & testing.
- Facilitating research.
- Providing trusted information.
Shaping the U.S. Response
July 20: ASM and Partners Call for Reversal of Administration Policy Bypassing CDC on COVID-19July 14: ASM Defends Science-Based Health Policy in Letter to Executive Branch
June 23: ASM and Stakeholders Urge HHS to Renew Public Health Declaration
June 23: ASM Reiterates Need for High-Level Review of Coronavirus Response
June 23: ASM Urges House Energy & Commerce Committee to Continue Efforts Toward Response and Recovery from the COVID-19 Pandemic
May 12: ASM Statement in Response to Senate HELP Committee Hearing on COVID-19
April 24: ASM Statement on the Paycheck Protection Program and Health Care Enhancement Act
April 21: ASM Endorses Bipartisan Letter in Support of Emergency Funding for Research Labs in Next COVID-19 Package
March 30: ASM Leads Stakeholder Letter Urging a Review of COVID-19 Response to Prepare for Future Pandemics
March 26: Breakdown of the Coronavirus Aid, Relief, and Economic Security (CARES) Act
March: 17 ASM Asks Congress for a High-Level, Comprehensive Review of the SARS-CoV-2 Response
March 4: ASM Applauds Action on Coronavirus Emergency Supplemental Appropriation
March 3: ASM Urges Senate Support for Coordinated Efforts to Combat COVID-19
Feb. 26: ASM Issues Response to House Hearing on FY2021 HHS Budget and Coronavirus
Feb. 5: ASM Responds to House Hearing on Wuhan Coronavirus
Leading on Diagnostics & Testing
July 10: ASM Advocates for Increased Access to Testing Supplies and PPEJuly 6: ASM Applauds Introduction of the TEST Act
July 1: ASM Statement on the Critical Role of Training Medical and Public Health Microbiologists in the Pandemic
June 24: Protocol to Verify Emergency Use Authorization (EUA) SARS-CoV-2 Antibody Tests
June 2: Small Study Demonstrates Sample Inactivation May Lead to SARS-CoV-2 False Negatives
May 4: ASM Thanks FDA for Clarifying SARS-CoV-2 Serology Test Guidance
April 27: White House Coronavirus Task Force Continues to Work with ASM to Ensure Their Testing Plans are Effective and Efficient
April 21: ASM Urges FDA to Affirm Role of Clinical Labs for COVID-19 Serology Testing
April 20: White House Coronavirus Task Force Looks to ASM for Assistance Mapping Testing Capacity and Equipment in Each State
April 17: White House Coronavirus Task Force Calls on ASM to Help Coordinate Testing Ramp Up
April 14: ASM Submits Letter to FDA Calling for Stronger Oversight of COVID-19 Serology Tests
April 3: Protocol to Verify Emergency Use Authorization (EUA) COVID-19 Diagnostic Tests
March 27: The Value of Diagnostic Testing for SARS-CoV-2: When, Whom, What and How Often To Test?
March 17: ASM Commends New Guidance to Increase COVID-19 Testing Capacity
March 11: A Possible Treatment for COVID-19 and an Approach for Developing Others
March 10: ASM Expresses Concern About Test Reagent Shortages
March 9: Expediting COVID-19 Testing and Expanding Access to Clinical Labs
Feb. 28: Amid COVID-19, ASM Voices Concerns about Clinical Access to Tests
Feb. 3: Novel Coronavirus Lab Protocols and Responses: Next Steps
Facilitating Research
May 4: Two Drugs Show Promise Against COVID-19
April 15: ASM Launches a COVID-19 Research Registry
March 27: ASM COVID-19 International Summit Sets Research Priorities
March 23: Antimicrobials and COVID-19: Strategies for Treating a Pandemic
March 23: Researchers Investigate Potential Treatments for COVID-19
Jan. 31: 2019 Novel Coronavirus (2019-nCoV) Update: Uncoating the Virus
Jan. 31: Sharing Research Data and Findings Relevant to the Novel Coronavirus (COVID-19) Outbreak
Jan. 30: Novel Coronavirus (COVID-19) Receptors Show Similarities to SARS-CoV, According to New Analysis
Jan. 30: ASM Provides Free Access to Coronavirus Research Articles
Providing Trusted Information
May 27: Coronavirus Webinar Series: The Microbial Sciences Respond to COVID-19May 20: ASM Hosts COVID-19 Webinar with CDC
May 4: ASM President Robin Patel addressed stakeholders on the weekly Centers for Disease Control and Prevention (CDC) Clinical Laboratory COVID-19 Response conference call. Her presentation discussed ASM's response to date to the pandemic, including support for research, support for clinical microbiologists, and communication with policymakers, stakeholders and the public. Access the recording, slides and call transcript.
March 20: Top COVID-19 Questions, Answered: An Interview with ASM President Robin Patel
Feb. 28: What to Know About the New Coronavirus: An Interview with Dr. Stanley Perlman
Jan. 30: Anthony Fauci Addresses Coronavirus at ASM Biothreats Conference